摘要
皮肤鳞状细胞癌(cSCC)是世界范围内最常见的非黑色素瘤皮肤癌之一。根据cSCC的特征及病人自身情况,将其分为高危型和低危型。cSCC大部分为低危型,容易治疗,但高危型cSCC可有较高的复发率和致死率。本文主要综述高危型cSCC近年来在临床治疗方面的最新研究进展。
出处
《齐鲁医学杂志》
2016年第2期246-248,251,共4页
Medical Journal of Qilu
基金
青岛市科技发展指导计划项目(KJZD-13-32-JCH)
参考文献29
-
1KARIA P S, JAMBUSARIA-PAHLAJANI A, HARRING- TON D P, et al. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma[J]. J Clin Oncol, 2014,32(4):327-334.
-
2ROSS A S, WHALEN F M, ELENITSAS R, et al. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study[J]. Dermatoi Surg, 2009,35 (12) 1859-1866.
-
3LIU L S, COLEGIO O R. Molecularly targeted therapies for nonmelanoma skin cancers[J]. Int J Derrnatol, 2013,52 (6) : 654-665.
-
4BRANTSCH K D, MEISNER C, SCHONFISCH B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study[J]. Lancet On- col, 2008,9(8) :713-720.
-
5SMITH K J, HAMZA S, SKELTON H. Histologic features in primary cutaneous squamous cell carcinomas in immuno- compromised patients focusing on organ transplant patients [J]. Dermatol Surg, 2004,30(4 Pt 2):634-641.
-
6MARTORELL-CALATAYUD A, SANMARTIN JIMENEZ O, CRUZ MOJARRIETA J, et al. Cutaneous squamous cell carcinoma: defining the high-risk variant[J]. Actas Dermosi- filiogr, 2013,104(5) : 367-379.
-
7ROWE D E, CARROLL R J, DAY C L, et al. Prognostic fac- tors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection[J]. J Am Acad Dermatol, 1992,26(6) :976-990.
-
8O'BRYAN K, SHERMAN W, NIEDT G W, et al. An evol- ving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2013,69 (4) : 595-602.
-
9YOON D Y, HWANG H S, CHANG S K, et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the as- sessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck[J]. Eur Radiol, 2009,19(3): 634-642.
-
10JAMBUSARIA-PAHLAJANI A, HESS S D, KATZ K A, et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mobs surgeons[J]. Arch Dermatol, 2010,146(11) :1225-1231.
二级参考文献25
-
1DISPENZIERI A C. Chemotherapy induced insulin dependent diabetes mellitus[J]. Clinical Oneology, 1997, 15 (3) : 1287- 1288.
-
2GOLDSTEIN R S, MAYOR G H, GINGERICH R L, et al. The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function[J]. Toxicology and Applied Pharmacology, 1983,69(3):432 -441.
-
3GOLDSTEIN R S, MAYOR G H, ROSENBAUM R W, et al. Glucose intolerance following cis-platinum treatment in rats [J]. Toxicology, 1982,24(3-4) :273-280.
-
4GHAVAMZADEH A, LARIJANI B, JAHANI M, et al Thyroid, parathyroid, gonadal, and pancreatic beta-cell func tion after bone marrow transplantation with chemotherapy-on ly conditioning[J]. Transplantation Proceedings, 2003,35 (8) 3101 3104.
-
5CVETKOVIC l, MILJKOVIC D, VUCKOVIC O, et al. Ta xol activates inducible nitric oxide synthase in rat astrocytes: the role of MAP kinases and NF-kappaB[J]. Cellular and Mo- lecular Life Sciences: CMLS, 2004,61(10).-1167-1175.
-
6MOSN H, SALEHI A, HENNINGSSQN R, et al. Nitric oxide inhibits, and carbon monoxide activates, islet acid a[pha- glueoside hydrolase activities in parallel with glucose-stimula- ted insulin secretion[J]. The Journal of Endocrinology, 2006, 190(3) : 681-693.
-
7THOMAS L E, THOMAS W H. Protection of NIT 1 pan- creatic β-cells from immune attack by inhibition of NF-kB[J]. Journal of Autoimmunity, 1997(10) 293 298.
-
8HO E, CHEN G, BRAY T M. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes[J]. Free Radical Biology & Medicine, 2000,28(4) 604-614.
-
9KUMAR A, NEGI G, StlARMA S S. Suppression of NF-kB and NF-kB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IkB phosphorylation inhibitor) in experimental diabetic neuropathy[J]. Biochimie, 2012,94(5) :1158-1165.
-
10BARZILAY J I, ABRAHAM L, HECKBERT S R, et al. The relation of markers of inflammation to the development of glu- cose disorders in the elderly: the Cardiovascular Health Study [J]. Diabetes, 2001,50(10) 2384-2389.
共引文献3
-
1张海峰,周建峰.肿瘤抑制因子VHL及其结合蛋白VBP1研究进展[J].齐鲁医学杂志,2015,30(5):620-622. 被引量:1
-
2丁雪丽,荆雪,田字彬,阎志程,杨林,陈文秀.脂多糖对HBsAg转染肝癌细胞核因子κB活化作用[J].青岛大学医学院学报,2016,52(1):1-3. 被引量:1
-
3师晓艳,冯艳,马园园.盐酸小檗碱片联合黄芪片对妇科恶性肿瘤术后化疗所致糖代谢异常的影响及其治疗机制[J].现代中西医结合杂志,2019,28(11):1173-1176. 被引量:4
同被引文献39
-
1高天文,孙东杰,李春英,何弘,李青,刘友生,刁庆春,黄高升,郝飞,钟白玉,马福成,柳凤轩,闫小初,刘东梅,刘玉峰,刘荣卿.中国西部两医院1905例皮肤恶性肿瘤回顾分析[J].北京大学学报(医学版),2004,36(5):469-472. 被引量:73
-
2张武,王昕,李铮,于娜.唇部鳞状细胞癌误诊为口唇单纯疱疹1例[J].中国误诊学杂志,2005,5(13):2590-2591. 被引量:1
-
3袁敬东,李云霞,胡琼华.颜面部皮肤恶性肿瘤26例手术治疗体会[J].实用癌症杂志,2006,21(4):426-427. 被引量:5
-
4王玮.整形外科学[M].浙江科学技术出版社,2007.
-
5Kallini JR, NouranHamed MD, FACMS AKMDF. Squamous cell carcinoma of the skin : epidemiology, classification, management, and novel trends[J]. Int J Dermatol, 2015,54(2) :130-140.
-
6Analysis of risk factors determining prognosis of cutaneous squa- mous-cell carcinoma: a prospective study [ J ]. Lancet Oncol, 2008,9(7) :713-720.
-
7Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin : European consensus- based interdisciplinary guideline [ J ]. Eur J Cancer, 2015,5l(14):1989-2007.
-
8Bonerandi JJ, Beauvillain C, Caquant L, et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions [ J]. J Eur Acad Dermatol Venereol, 2011, 25 Suppl 5 : 1-51.
-
9Newlands C, Gurney B. Management of regional metastatic disease in head and neck cutaneous malignancy. 2. Cutaneous malignant melanoma[J]. Br J Oral Maxillofac Surg, 2014,52(4):301-307.
-
10Iyer NG, Clark JR, Murali R, et al. Outcomes following parotld- ectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation [ J ]. Head Neck, 2009,31 ( 1 ) :21-27.
引证文献5
-
1潘腾,冯晓玲.皮肤鳞状细胞癌的治疗进展[J].中国美容整形外科杂志,2016,27(8):488-491. 被引量:6
-
2吴芳芳,谢杰,阙守红,刘雅慧,杨斌.唇部寻常疣继发鳞状细胞癌[J].皮肤性病诊疗学杂志,2016,23(6):365-366.
-
3陈红波,潘腾,冯晓玲.65例头面部鳞状细胞癌回顾性分析[J].中国美容整形外科杂志,2017,28(4):212-214. 被引量:6
-
4张琦,韦永中,李威,李菊明,黄宇旻.手足部恶性肿瘤的治疗及预后探讨[J].肿瘤学杂志,2018,24(6):640-643. 被引量:3
-
5刘楠,王傲,白彦萍.高剂量7,12-二甲基苯并[a]蒽诱发的小鼠皮肤鳞状细胞癌模型建立及评价[J].海南医学院学报,2020,26(2):92-96. 被引量:4
二级引证文献18
-
1陈娅,韩兆峰,朱怡梦,曹俊华,李志斌.初治皮肤鳞癌的临床特点及整形外科手术治疗效果[J].河南医学研究,2019,28(4):612-613. 被引量:1
-
2李超,陈永锋.皮肤鳞状细胞癌的研究进展[J].皮肤性病诊疗学杂志,2019,26(1):49-52. 被引量:13
-
3罗燕群,万学峰.慢Mohs显微描记手术在皮肤恶性肿瘤中的应用进展[J].中国美容医学,2019,28(8):169-173. 被引量:2
-
4沈聪聪,姚晓东,顾黎雄.手术扩大切除联合全厚植皮治疗面部皮肤鳞状细胞癌的效果观察[J].南通大学学报(医学版),2019,39(5):353-355. 被引量:2
-
5刘楠,王傲,白彦萍.高剂量7,12-二甲基苯并[a]蒽诱发的小鼠皮肤鳞状细胞癌模型建立及评价[J].海南医学院学报,2020,26(2):92-96. 被引量:4
-
6邹易恒,李威,吴越,孟祥实,王兴强,曹梅,孙美超.蒽对脊尾白虾存活、免疫和能量分配的影响[J].河北渔业,2020,0(3):13-17. 被引量:1
-
7杨俊武,艾勇.面部鳞状细胞癌术后复发并下颌骨转移1例[J].皮肤科学通报,2020,37(3):309-312.
-
8彭玉梅,阳贵诚.高龄患者颞部巨大鳞癌切除后等面积取皮法植皮1例[J].皮肤科学通报,2020,37(3):323-325.
-
9鲍琼,曹东升,李红红,谢娟,娄寅,朱邦中.局部皮瓣在颜面部常见肿瘤切除后创面修复中的应用[J].实用医学杂志,2020,36(13):1854-1856. 被引量:8
-
10彭勇,王亮.颅脑MRI增强扫描联合纹理分析技术在鉴别脑胶质瘤与脑转移瘤中的价值[J].中国中西医结合影像学杂志,2020,18(6):586-589. 被引量:6
-
1周晓鸿.皮肤鳞状细胞癌[J].皮肤病与性病,2015,37(3):143-144. 被引量:11
-
2咖啡因能抵御皮肤癌[J].中老年保健,2009(5):6-6.
-
3张嘉辉,毕良佳.光动力疗法治疗非黑色素瘤皮肤癌的研究进展[J].实用肿瘤学杂志,2016,30(1):71-74. 被引量:5
-
4口服烟酰胺(VB3)可降低皮肤癌风险[J].实用肿瘤学杂志,2015,29(6):532-532.
-
5张玢.高危非黑色素瘤皮肤癌的前哨淋巴结活检[J].国外医学情报,2004,25(5):39-39.
-
6Arif M Aslam,Anand N Patel,陈佳佳,杜长征.面部皮肤鳞状细胞癌[J].英国医学杂志中文版,2017,20(1):25-31.
-
7Weissenborn S.J.,Nindl I.,Purdie K.,李政霄.光化性角化病的人乳头瘤病毒DNA含量超过非黑色素瘤皮肤癌患者[J].世界核心医学期刊文摘(皮肤病学分册),2005,0(11):16-16. 被引量:1
-
8张博恒.皮肤癌变,哪些是祸根[J].抗癌,2004(2):13-14.
-
9咖啡因有助抵御皮肤癌[J].生命世界,2009(4):4-4.
-
10金达(译),杜昕(校).发生首次非黑色素瘤皮肤癌后,其他癌的发病风险略有提高[J].英国医学杂志中文版,2013,16(4):208-208.